Stocks INLF Financial statements
Financial statementsINLIF Ltd financial statements
Income statement, balance sheet and cash flow statement for the last 4 fiscal years, taken from the XBRL data INLIF Ltd files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
| FY2022 | FY2024 | FY2024 | FY2025 | |
|---|---|---|---|---|
| Revenue | 6.65 | 12.6 | 15.8 | 18.4 |
| Cost of revenue | 4.36 | 8.45 | 11.2 | 14.1 |
| Gross profit | 2.29 | 4.16 | 4.58 | 4.29 |
| Research and development | 0.5 | 1.36 | 1.56 | 2.07 |
| General and administrative | 0.74 | 0.72 | 0.76 | 7.09 |
| Operating expenses | 1.64 | 2.77 | 3.27 | 10.1 |
| Operating income | 0.65 | 1.39 | 1.29 | -5.82 |
| Interest expense | 0.08 | 0.15 | 0.2 | 0.16 |
| Interest income | 0 | 0.01 | 0 | 0 |
| Other non-operating income | -0.11 | -0.02 | 0.33 | 0.37 |
| Pre-tax income | 0.54 | 1.36 | 1.62 | -5.45 |
| Income tax | -0 | 0.01 | 0.01 | -0 |
| Net income | 0.54 | 1.35 | 1.61 | -5.45 |
| EBITDA | 1.04 | 1.75 | 1.64 | -5.53 |
| EPS, basic | 0.04 | 0.11 | 0.13 | -0.33 |
| EPS, diluted | 0.04 | 0.11 | 0.13 | -0.33 |
| Shares, basic (weighted) | 12.5 | 12.5 | 12.5 | 16.6 |
| Shares, diluted (weighted) | 12.5 | 12.5 | 12.5 | 16.6 |
Balance sheet
| FY2022 | FY2024 | FY2024 | FY2025 | |
|---|---|---|---|---|
| Cash and equivalents | 0.08 | 0.6 | 2.47 | 6.72 |
| Receivables | 3.79 | 3.84 | 5.91 | |
| Inventory | 4.49 | 5.3 | 5.5 | |
| Other current assets | 0.12 | 0.01 | 0.1 | |
| Total current assets | 9.38 | 13.3 | 18.2 | |
| Property, plant and equipment | 3.4 | 3.04 | 4.25 | |
| Intangible assets | 0.05 | 0.04 | 0.04 | |
| Total assets | 16 | 18.5 | 24.8 | |
| Accounts payable | 2.55 | 3.13 | 3.29 | |
| Accrued liabilities | 0.12 | 0.14 | 0.21 | |
| Deferred revenue | 0.07 | 0 | 0.01 | |
| Short-term debt | 3.66 | 4.63 | 4.62 | |
| Total current liabilities | 7.06 | 8.2 | 8.63 | |
| Total liabilities | 7.06 | 8.2 | 8.64 | |
| Paid-in capital | 7.04 | 7.04 | 17.7 | |
| Retained earnings | 1.76 | 3.2 | -2.24 | |
| Other comprehensive income | -0.03 | -0.34 | 0.29 | |
| Shareholders' equity | 7.84 | 8.96 | 10.3 | 16.1 |
| Total equity | 7.84 | 8.96 | 10.3 | 16.1 |
| Total liabilities and equity | 16 | 18.5 | 24.8 | |
| Shares outstanding | 12.5 | 12.5 |
Cash flow statement
| FY2022 | FY2024 | FY2024 | FY2025 | |
|---|---|---|---|---|
| Net income | 0.54 | 1.35 | 1.61 | -5.45 |
| Depreciation and amortization | 0.39 | 0.37 | 0.35 | 0.29 |
| Stock-based compensation | 5.14 | |||
| Deferred income tax | -0 | 0 | -0 | -0 |
| Change in receivables | -0.72 | -1.55 | -0.05 | -2.08 |
| Change in inventory | 1.09 | -2.03 | -0.81 | -0.2 |
| Change in payables | 2.06 | 0.59 | 0.15 | |
| Cash from operations | 1.24 | 0.4 | 1.58 | -1.89 |
| Capital expenditures | -0.02 | -0.22 | -0.03 | -0.19 |
| Cash from investing | -0.02 | -0.22 | 0.32 | -0.2 |
| Stock issued | 7.03 | |||
| Cash from financing | -1.72 | 0.46 | 0.22 | 6.87 |
| Exchange rate effect | 0.4 | -0.13 | -0.26 | -0.52 |
| Net change in cash | -0.1 | 0.51 | 1.87 | 4.25 |
| Free cash flow | 1.22 | 0.18 | 1.55 | -2.08 |
| Interest paid | 0.08 | 0.14 | 0.19 | 0.37 |
| Income taxes paid | 0 | 0 | 0 | 0.02 |
Key metrics
Profitability
| Metric | Value | How it is calculated |
|---|---|---|
| Gross margin | 23.3% | Gross profit / revenue. |
| Operating margin | -31.6% | Operating income / revenue. |
| EBITDA margin | -30.0% | EBITDA (operating income + depreciation and amortization) / revenue. |
| Pre-tax margin | -29.6% | Pre-tax income / revenue. |
| Net margin | -29.6% | Net income / revenue. |
| FCF margin | -11.3% | Free cash flow (cash from operations - capital expenditures) / revenue. |
| Operating cash flow margin | -10.3% | Cash from operations / revenue. |
| Return on equity (ROE) | -41.3% | Net income / average shareholders' equity (opening and closing). Not shown when equity is negative. |
| Return on assets (ROA) | -25.2% | Net income / average total assets. |
| Return on invested capital (ROIC) | -53.4% | Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%. |
| R&D / revenue | 11.2% | Research and development expense / revenue. |
| Stock-based pay / revenue | 27.9% | Stock-based compensation (from the cash flow statement) / revenue. |
| Capex / revenue | 1.0% | Capital expenditures / revenue. |
| D&A / revenue | 1.6% | Depreciation and amortization / revenue. |
Growth
| Metric | Value | How it is calculated |
|---|---|---|
| Revenue growth, 1y | 16.5% | Revenue vs the same period a year earlier. Only from a positive base. |
| Revenue CAGR, 3y | 40.4% | Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Gross profit growth, 1y | -6.3% | Gross profit vs the same period a year earlier. Only from a positive base. |
| Gross profit CAGR, 3y | 23.2% | Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating income growth, 1y | -551.8% | Operating income vs the same period a year earlier. Only from a positive base. |
| EBITDA growth, 1y | -438.0% | EBITDA vs the same period a year earlier. Only from a positive base. |
| Net income growth, 1y | -439.0% | Net income vs the same period a year earlier. Only from a positive base. |
| EPS growth, 1y | -353.8% | EPS vs the same period a year earlier. Only from a positive base. |
| Operating cash flow growth, 1y | -219.7% | Operating cash flow vs the same period a year earlier. Only from a positive base. |
| Free cash flow growth, 1y | -234.1% | Free cash flow vs the same period a year earlier. Only from a positive base. |
| Book value growth, 1y | 57.2% | Book value vs the same period a year earlier. Only from a positive base. |
| Book value CAGR, 3y | 27.2% | Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Total assets growth, 1y | 34.2% | Total assets vs the same period a year earlier. Only from a positive base. |
| Share count change, 1y | 32.6% | Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 3y | 9.9% | Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution. |
Balance sheet health
| Metric | Value | How it is calculated |
|---|---|---|
| Current ratio | 2.11x | Current assets / current liabilities. |
| Quick ratio | 1.46x | (Cash + short-term investments + receivables) / current liabilities. |
| Cash ratio | 0.78x | (Cash + short-term investments) / current liabilities. |
| Liabilities / assets | 34.9% | Total liabilities / total assets. |
| Interest coverage | -37.0x | Operating income / interest expense. |
| Working capital | $9.6M | Current assets - current liabilities. |
| Goodwill and intangibles / assets | 0.2% | (Goodwill + intangible assets) / total assets. |
| Tangible book value | $16.1M | Shareholders' equity - goodwill - intangible assets. |
Efficiency
| Metric | Value | How it is calculated |
|---|---|---|
| Asset turnover | 0.85x | Revenue / average total assets. |
| Fixed asset turnover | 5.05x | Revenue / average property, plant and equipment. |
| Inventory turnover | 2.61x | Cost of revenue / average inventory. |
| Days inventory | 140 days | 365 x average inventory / cost of revenue. |
| Receivables turnover | 3.78x | Revenue / average receivables. |
| Days sales outstanding | 97 days | 365 x average receivables / revenue. |
| Days payables | 83 days | 365 x average accounts payable / cost of revenue. |
| Cash conversion cycle | 153 days | Days inventory + days sales outstanding - days payables. |
Per share
| Metric | Value | How it is calculated |
|---|---|---|
| EPS, diluted | -$0.33 | Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS. |
| EPS, basic | -$0.33 | Net income per basic share, as reported (split-adjusted). |
| Revenue per share | $1.11 | Revenue / diluted weighted shares. |
| FCF per share | -$0.13 | Free cash flow / diluted weighted shares. |
| Operating cash flow per share | -$0.11 | Cash from operations / diluted weighted shares. |
| Book value per share | $0.97 | Shareholders' equity / shares outstanding (diluted weighted shares when not reported). |
| Tangible book per share | $0.97 | Tangible book value / shares outstanding. |
| Cash per share | $0.41 | (Cash + short-term investments) / shares outstanding. |
Valuation
| Metric | Value | How it is calculated |
|---|---|---|
| Market cap | $5.6M | Share price x shares outstanding. |
| Enterprise value | -$1.2M | Market cap + total debt - cash - short-term investments. |
| P/S | 0.30x | Market cap / revenue. |
| P/B | 0.34x | Market cap / shareholders' equity. Only when equity is positive. |
| Price / tangible book | 0.35x | Market cap / tangible book value, when positive. |
| FCF yield | -37.5% | Free cash flow / market cap. |
| Earnings yield | -97.9% | Net income / market cap (the inverse of P/E). |
What was INLIF Ltd's revenue in fiscal 2025?
INLIF Ltd reported revenue of $18.4M for fiscal 2025, 16.5% higher than the year before.
Was INLIF Ltd profitable in fiscal 2025?
No. It reported a net loss of $5.4M.
How much free cash flow did INLIF Ltd generate in fiscal 2025?
Cash from operations of $1.9M minus capital expenditures of $192.5K left free cash flow of -$2.1M.